Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
D003622:Dapsone / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D007539:Isonicotinic Acids / Q000627:therapeutic use*; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy*; D011515:Prothionamide / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*
D004338:Drug Combinations; D007539:Isonicotinic Acids; D007917:Leprostatic Agents; D011515:Prothionamide; D003622:Dapsone; D007538:Isoniazid; D012293:Rifampin